V J Bio
Stand: P5
- Advanced Therapies Europe
- Exhibitor
)
)
VJ Bio is a contract development and manufacturing organization (CDMO) providing high-quality plasmid DNA and recombinant protein solutions that accelerate the development of next-generation advanced therapies. We support biotechnology companies, academic institutions, and research organizations worldwide with manufacturing services spanning early discovery through clinical development.
Our expertise includes molecular biology, process development, analytical testing, and scalable manufacturing for applications including viral vector production, mRNA manufacturing, genome editing, and DNA vaccines. We also produce high-quality recombinant proteins for advanced therapies, including enzymes, nucleases, and cytokines. Our flexible manufacturing approach enables clients to efficiently advance programs while maintaining high quality standards and responsive technical support.
VJ Bio's integrated capabilities include construct design support, process optimization, analytical characterization, and quality control testing. By combining scientific expertise with efficient manufacturing workflows, we help reduce development timelines while delivering the consistency and reliability required for advanced therapeutic applications.
We are committed to building long-term partnerships through technical expertise, transparent communication, and customized solutions tailored to each client's needs. Whether supporting emerging biotechnology companies or established pharmaceutical organizations, VJ Bio emphasizes collaboration throughout every stage of development.
As demand for advanced therapies continues to grow, VJ Bio is expanding its manufacturing capabilities and investing in innovative technologies to better serve our clients. Through our commitment to scientific excellence, operational quality, and customer success, VJ Bio aims to be a trusted partner helping bring transformative therapies to patients around the world.
Our expertise includes molecular biology, process development, analytical testing, and scalable manufacturing for applications including viral vector production, mRNA manufacturing, genome editing, and DNA vaccines. We also produce high-quality recombinant proteins for advanced therapies, including enzymes, nucleases, and cytokines. Our flexible manufacturing approach enables clients to efficiently advance programs while maintaining high quality standards and responsive technical support.
VJ Bio's integrated capabilities include construct design support, process optimization, analytical characterization, and quality control testing. By combining scientific expertise with efficient manufacturing workflows, we help reduce development timelines while delivering the consistency and reliability required for advanced therapeutic applications.
We are committed to building long-term partnerships through technical expertise, transparent communication, and customized solutions tailored to each client's needs. Whether supporting emerging biotechnology companies or established pharmaceutical organizations, VJ Bio emphasizes collaboration throughout every stage of development.
As demand for advanced therapies continues to grow, VJ Bio is expanding its manufacturing capabilities and investing in innovative technologies to better serve our clients. Through our commitment to scientific excellence, operational quality, and customer success, VJ Bio aims to be a trusted partner helping bring transformative therapies to patients around the world.